Julius Clinical
Quinton Tennant currently serves as the Head of Finance and Accounting at Julius Clinical since May 2025. Prior to this role, Quinton held the position of International Senior Group Controller at Van Ameyde Group from April 2023 to May 2025 and was the Manager of Accounting Financial Reporting at MediaMarkt Nederland from March 2021 to March 2023. Previous experience includes working as an Audit Manager at Finchtree BV from May 2019 to February 2021, an Audit Senior at BDO Nederland from January 2018 to April 2019, and an Audit Trainee at BDO South Africa from January 2015 to December 2017. Quinton's educational background includes a Bachelor of Commerce in Accounting Sciences from the University of Pretoria and various qualifications from the South African Institute of Chartered Accountants.
This person is not in any teams
This person is not in any offices
Julius Clinical
At Julius Clinical, science is the foundation. Combined with flexibility, creativity, and innovation, our scientific approach enables fast, efficient, and high quality execution of complex clinical development programs. Our skilled and loyal networks of investigators all around the world allow us to offer superior recruitment in therapeutic area’s such as cardiology, diabetes, CNS and infectious diseases. Our partners include leading pharmaceutical, biotech, medical device, and food companies, as well as academic investigators. We focus on clinical trials that are likely to have a major impact on medicine and on people’s lives. This type of demanding research requires more than a ‘one-size-fits-all’ approach, and our fusion of scientific and operational expertise enables to deliver results efficiently, on time and budget. Julius Clinical has on its staff internationally recognised academic leaders who are actively involved in the design, conduct, and interpretation of clinical trials. This scientific expertise and credibility, combined with personal links with peers around the world, means that the company has a truly global reach and reputation. Through our global networks we can quickly select the most appropriate and high-performing sites to take part in a trial, and ensure that investigators are inspired and motivated.